cabozantinib Archives - Alliance Clinical Trials

Prostate Cancer Awareness Month: How Alliance Clinical Trials Help Reshape Early Detection and Improve Treatments

August 31, 2026

September is Prostate Cancer Awareness Month, and the Alliance for Clinical Trials in Oncology is highlighting the importance of clinical research in advancing better treatments and improving early detection to ultimately help prevent and cure prostate cancer. On average, men in the United States have about a 1 in 8 chance of developing prostate cancer…

Uncategorized

Alliance Reports Results from First Randomized Trial of a Radiopharmaceutical in Kidney Cancer

August 17, 2026

RadiCaL study results show adding bone-targeting radium-223 to cabozantinib does not improve symptomatic skeletal-related events, highlighting the value of current standard treatments to optimize bone health for patients with bone metastases. Results from the Alliance for Clinical Trials in Oncology’s Phase II RadiCaL trial (Alliance A031801), the first randomized study of a radiopharmaceutical in kidney…

Uncategorized

Highlighting Alliance Progress and Impact in Research through News Reports

May 8, 2026

Highlighting Alliance Progress and Impact in Research through News Reports At the Alliance for Clinical Trials in Oncology, we love sharing stories that show what’s happening in cancer research right now. Whether it’s a new clinical trial, a scientific breakthrough, or the work of one of our dedicated investigators, we want people to see the…

Cancer Control Gastrointestinal Cancer Genitourinary Cancer Leukemia Respiratory Cancer